Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

People with multiple sclerosis (MS) have altered levels of several key bacteria in the mouth, a new study reports.

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

Having a higher BMI at diagnosis is tied to faster disability progression in people with multiple sclerosis, according to a ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

It’s also worth noting that even if you have MS disability benefits through Social Security, you do not automatically receive ...

Jill Blackburn, a pediatric MS mom, founded the Pediatric Multiple Sclerosis Alliance to help other families of kids with the ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

Researchers identified a protein in mouse models that acts as a brake on myelin production, which could be a target for new MS treatments.